Clarapath

Clarapath Overview

Founded 2014
Founded
Status Private
Latest Deal Type Series B
Latest Deal Amount $20M
Latest Deal Amount
Investors 5

Clarapath General Information

Description

Developer of an integrated histology platform designed to standardize and digitally transform anatomic pathology. The company's platform include sectioning, staining and whole slide imaging and are supported through the combination of automated high-definition "tissue-to-bits" histopathology lab and diagnostic and decision support software platform that automates biomarker detection and analysis, enabling clinical pathology laboratories to transform clinical pathology and improve patient care cost effectively.

Contact Information

Formerly Known As
pTerapipe
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Diagnostic Equipment
Other Industries
Other Healthcare Technology Systems
Medical Records Systems
Primary Office
  • 101 6th Avenue
  • New York, NY 10013
  • United States
+1 (347) 000-0000

Clarapath Timeline

2017201820192020
Financing Round
Want detailed data on 2M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Clarapath Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Early Stage VC (Series B) 11-Nov-2019 $20M 000.00 0000 Completed Product Development
3. Early Stage VC (Series A1) 01-Feb-2017 00.00 00.00 000.00 Completed Product Development
2. Grant 01-Jan-2016 $100K $3M Completed Startup
1. Early Stage VC (Series A) 03-Jul-2014 $3M $3M 0000 Completed Startup

Clarapath Cap Table

To view Clarapath‘s complete cap table, request access »
Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series B 00,000,000 00.000000 00 00.00 00.00 00 00.00 00.000
Series A-1 0,000,000 00.000000 00 00 00 00 00 00.000
Series A 3,700,000 $0.001000 8% $1 $1 1x $1 12.47%

Clarapath Executive Team (5)

Name Title Board Seat Contact Info
Kavita Sethi Director, Finance & Human Resources
Partha Mitra Ph.D Co-Founder, Chief Scientist & Board Member
Eric Feinstein Executive Director & Board Member

2 Former Executives

Clarapath Board Members (7)

To view Clarapath‘s full board member team, request access »
Name Representing Role Since
Charles Cantor Ph.D Self Board Member 000 0000
Eric Feinstein Clarapath Executive Director & Board Member 000 0000
James Crawford Ph.D Self Board Member 000 0000
Michael Shelanski Ph.D Self Board Member 000 0000
Partha Mitra Ph.D Clarapath Co-Founder, Chief Scientist & Board Member 000 0000

1 Former Board Member

Clarapath Investors (5)

To view Clarapath‘s full investor history, request access »
Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Epiphron Capital Venture Capital Minority 000 0000 000000 0
Evolution VC Partners Venture Capital Minority 000 0000 000000 0
P5 Health Ventures Venture Capital Minority 000 0000 000000 0
Northwell Ventures Corporate Venture Capital Minority 000 0000 000000 0
United States Department of Defense Government 000 0000 000000 0

Ready to get started?

Request a free trial